Iran reveals domestically-made medicine for Parkinson’s disease
Previously produced and supplied by a Swiss company, Loparkin formulation has been found for the Iranian medicine company to meet the demands of %1 elderly Iranians suffering from the disease.
Iranian patients have made the majority of victims to western sanctions.
The move has been made on early days of the Persian New Year named as the year to support domestic products by Iran’s Supreme Leader, Ayatollah Khamenei.
Parkinson’s disease symptoms include muscle rigidity, tremors, and changes in speech and gait. After diagnosis, treatments can help relieve symptoms, but there is no cure for a disease which targets the nerve cells in the brain that produce dopamine.